Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia.

Freeman D, Dunn G, Murray RM, Evans N, Lister R, Antley A, Slater M, Godlewska B, Cornish R, Williams J, Di Simplicio M, Igoumenou A, Brenneisen R, Tunbridge EM, Harrison PJ, Harmer CJ, Cowen P, Morrison PD.

Schizophr Bull. 2014 Jul 15. pii: sbu098. [Epub ahead of print]

PMID:
25031222
[PubMed - as supplied by publisher]
Free Article
2.

[Short-and long-term effects of cannabinoids on memory, cognition and mental illness].

Sagie S, Eliasi Y, Livneh I, Bart Y, Monovich E.

Harefuah. 2013 Dec;152(12):737-41, 751. Review. Hebrew.

PMID:
24483000
[PubMed - indexed for MEDLINE]
3.

Genetic dissection of the psychotomimetic effects of cannabinoid exposure.

O'Tuathaigh CM, Gantois I, Waddington JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:33-40. doi: 10.1016/j.pnpbp.2013.11.002. Epub 2013 Nov 12.

PMID:
24239593
[PubMed - in process]
4.

Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.

Chadwick B, Miller ML, Hurd YL.

Front Psychiatry. 2013 Oct 14;4:129. doi: 10.3389/fpsyt.2013.00129. Review.

PMID:
24133461
[PubMed]
Free PMC Article
5.

Therapeutic potential of cannabinoid medicines.

Robson PJ.

Drug Test Anal. 2014 Jan-Feb;6(1-2):24-30. doi: 10.1002/dta.1529. Epub 2013 Sep 4. Review.

PMID:
24006213
[PubMed - indexed for MEDLINE]
6.

Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.

Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM, Marcelis M, Van Laere K, Henquet C.

PLoS One. 2013 Jul 25;8(7):e70378. doi: 10.1371/journal.pone.0070378. Print 2013.

PMID:
23936196
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cannabis psychosis: examining the evidence for a distinctive psychopathology in a systematic and narrative review.

Baldacchino A, Hughes Z, Kehoe M, Blair H, Teh Y, Windeatt S, Crome IB.

Am J Addict. 2012 Nov;21 Suppl 1:S88-98. doi: 10.1111/j.1521-0391.2012.00295.x. Review.

PMID:
23786516
[PubMed - indexed for MEDLINE]
8.

Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.

Gomes FV, Del Bel EA, Guimarães FS.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:43-7. doi: 10.1016/j.pnpbp.2013.06.005. Epub 2013 Jun 19.

PMID:
23791616
[PubMed - indexed for MEDLINE]
Free Article
9.

Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis.

Chan WL, Wood DM, Hudson S, Dargan PI.

J Med Toxicol. 2013 Sep;9(3):278-81. doi: 10.1007/s13181-013-0306-y.

PMID:
23733714
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms.

Morgan CJ, Page E, Schaefer C, Chatten K, Manocha A, Gulati S, Curran HV, Brandner B, Leweke FM.

Br J Psychiatry. 2013 May;202(5):381-2. doi: 10.1192/bjp.bp.112.121178. Epub 2013 Apr 11.

PMID:
23580381
[PubMed - indexed for MEDLINE]
Free Article
11.

Cannabis, psychosis and the thalamus: a theoretical review.

Vukadinovic Z, Herman MS, Rosenzweig I.

Neurosci Biobehav Rev. 2013 May;37(4):658-67. doi: 10.1016/j.neubiorev.2013.02.013. Epub 2013 Feb 28. Review.

PMID:
23458778
[PubMed - indexed for MEDLINE]
12.

[Marihuana and cannobinoids as medicaments].

Tkaczyk M, Florek E, Piekoszewski W.

Przegl Lek. 2012;69(10):1095-7. Review. Polish.

PMID:
23421098
[PubMed - indexed for MEDLINE]
13.

Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Sharma P, Murthy P, Bharath MM.

Iran J Psychiatry. 2012 Fall;7(4):149-56.

PMID:
23408483
[PubMed]
Free PMC Article
14.

The effect of marijuana use on the risk for schizophrenia.

Evins AE, Green AI, Kane JM, Murray RM.

J Clin Psychiatry. 2012 Nov;73(11):1463-8. doi: 10.4088/JCP.12012co1c. No abstract available.

PMID:
23218162
[PubMed - indexed for MEDLINE]
15.

Medical use of cannabis. Cannabidiol: a new light for schizophrenia?

Deiana S.

Drug Test Anal. 2013 Jan;5(1):46-51. doi: 10.1002/dta.1425. Epub 2012 Oct 25.

PMID:
23109356
[PubMed - indexed for MEDLINE]
16.

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.

Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3364-78. doi: 10.1098/rstb.2011.0389. Review.

PMID:
23108553
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.

Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S.

J Psychopharmacol. 2013 Jan;27(1):19-27. doi: 10.1177/0269881112460109. Epub 2012 Oct 5.

PMID:
23042808
[PubMed - indexed for MEDLINE]
18.

Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.

Atakan Z, Bhattacharyya S, Allen P, Martín-Santos R, Crippa JA, Borgwardt SJ, Fusar-Poli P, Seal M, Sallis H, Stahl D, Zuardi AW, Rubia K, McGuire P.

Psychol Med. 2013 Jun;43(6):1255-67. doi: 10.1017/S0033291712001924. Epub 2012 Oct 1.

PMID:
23020923
[PubMed - indexed for MEDLINE]
19.

Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research.

Schoedel KA, Harrison SJ.

Curr Pharm Des. 2012;18(32):5008-14. Review.

PMID:
22716155
[PubMed - indexed for MEDLINE]
20.

Anandamide dysfunction in prodromal and established psychosis.

Leweke FM.

Curr Pharm Des. 2012;18(32):5188-93. Review.

PMID:
22716147
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk